1 / 23

Thromboembolic complications in IBD

Thromboembolic complications in IBD. Athos Bousvaros MD, MPH Associate Director, IBD Center. With gratitude. Naamah Zitomersky. Cameron Trenor. Menno Verhave. Thrombosis and IBD: A call for improved awareness and prevention. IBD Journal 2011 17:458. Overview. Pathophysiology

alodie
Download Presentation

Thromboembolic complications in IBD

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Thromboembolic complications in IBD Athos Bousvaros MD, MPH Associate Director, IBD Center

  2. With gratitude Naamah Zitomersky Cameron Trenor Menno Verhave Thrombosis and IBD: A call for improved awareness and prevention. IBD Journal 2011 17:458

  3. Overview • Pathophysiology • Risks of venous thromboembolism • Relative • Absolute • Risk factors • Workup of thromboembolic event • Prophylaxis • Treatment

  4. Arterial vs. venous thromboembolism • Arterial • Clot in an artery (carotid, coronary, SMA) • Rare in younger patients (under 40 years) • Preventable with antiplatelet drugs (ASA) • Venous • Clot in venous system • Deep venous thrombosis (usually in leg or arm) • Preventable with anticoagulation (heparin, coumadin)

  5. Coagulation cascade PROTEIN S PROTEIN C ANTI- THROMBIN www.ecc-book.com

  6. www.ecc-book.com

  7. Risk factors in the general population • Hereditary thrombophilias • Factor V Leiden mutation • 5% of Caucasians, 2% Hispanics, 1% African Americans • Prothrombin gene mutation (G20210A) • 2% of Caucasians • Protein C, Protein S, Antithrombin 3 deficiencies • Environmental causes • Smoking, oral contraceptives • Surgery, immobility

  8. Why are IBD patients especially at risk? • Inflammation and disease activity • Increased fibrinogen • Increased D-dimer • Increased factors V, VIII, IX • Prothrombotic antibodies (antiphospholipid) • Endothelial damage • Increased homocysteine • Prothrombotic medications • thalidomide

  9. No Risk Factor Inflammationis the Most Common Risk Factor; DVT without a Risk Factor is Rare in Children (n=82) Infl Lupus Anticoag Infec CVL NEJM 2004;351:1081-8.

  10. Venous thromboembolism (VTE) in inflammatory bowel disease • Relative risk is high • Six fold greater hazard ratio in < 20 years old* • Mainly in patients with flares** • Absolute risk is low • 2811 IBD patients recruited over 2.5 yrs*** • 116 (4%) of patients developed de novo VTE • Mean age 42 years • Risk of recurrence high if anticoagulation stopped *Kappelman et al; Gut 2011 Nylund et al; JPGN 2013 ** Grainge et al, Lancet 2010 *** Novacek, Gastro 2010

  11. What complications occur with increased frequency in adults? • Meta analysis of over 200,000 patients – increased risk of venous, but not arterial events. • Deep venous thrombosis RR 2.4 • Pulmonary embolism RR 2.5 • Ischemic heart disease RR 1.3 • Mesenteric ischemia RR 3.4 Fumery et al, J. Crohn’s Colitis 2013

  12. IBD Clot rates – Boston Children’s *3.82 symptomatic events per 1000 catheter days Zitomersky et al, JPGN 2013; 57:343-7

  13. A major source of morbidity IVC clot needing filter in severe UC

  14. Is heparin prophylaxis indicated? • Not in outpatients, unless another reason • “Prophylaxis would be needed for 312 person-years of IBD flares to prevent one person developing venous thromboembolism” – G. Nguyen, Lancet • Yes in inpatients • Included in AGA physician performance measure set, but only 35% of gastroenterologists use it.* • “…heparin has an important role in prophylaxis against thromboembolism in patients admitted to hospital with severe colitis” – Kornbluth and Sachar, ACG Guideline 2010 *Tinsley, J. ClinGastroenterol 2013

  15. Prophylactic Anticoagulation for High Risk Colitis patients • Continue anticoagulation until either: • Discharge • Resolution of colitis, or • Baseline mobility, if post-op No personal or strong family history of bleeding Pre-pubertal or < 40kg Enoxaparin 0.5 mg/kg BID Post-pubertal or > 40kg Enoxaparin 40 mg daily

  16. The “ouch” factor

  17. Colitis: New diagnosis or Admission • Review family history for thrombosis AND bleeding • Address dehydration • Address immobility (PT consultation, plan for ambulation) • Alternatives to combined oral contraception • Counsel about smoking, inactivity, long travel • Consider • factor VIII • D-dimer • lupus anticoagulant • anti-cardiolipin and anti-2 glycoprotein 1 antibodies

  18. Proposed High Risk Definition Personal history thrombosis, 1st degree family history, Known thrombophilia,# OCPs, Smoking > 1ppd, BMI > 35 OR PICC/Broviac/Port-a-Cath (especially if ASD) thalidomide High Risk Inpatient colitis OR Major surgery *awareness if elevated factor VIII, D-dimer, isolated APLA #Known thrombophilia = factor V Leiden, prothrombin gene mutation, low protein C/S or antithrombin function, persistent APLA >40 for >12 weeks

  19. Evaluation of DVT • High index of suspicion • Headache, vomiting • Extremity swelling • Labs • D-dimer excellent negative predictive value • Imaging • Ultrasound of extremity and femoral veins • MR or MR venography preferred for CNS • Spiral CT for pulmonary embolism • Cardiac echocardiogram for patent foramen

  20. Therapy of clots (adult and pediatric) • Unfractionated heparin • 75 U/kg bolus • 18 U/kg/hour • Goal anti-Xa level, 0.3-0.5 U/ml • Low molecular weight heparin (enoxaparin) • 1mg/kg sc bid • Goal anti-Xa level 0.5-1 U/ml • Warfarin for long term management? • Colectomy may be life-saving • Timing of colectomy is tricky

  21. Additional therapy • Catheter directed thrombolysis • Inferior vena cava filter • Protect against pulmonary emboli • Surgical thrombectomy • When thrombolysis contraindicated • Is a large clot complicating severe colitis an indication for colectomy? • What is optimal timing for the colectomy? • Control colitis medically, treat clot, then operate

  22. Is heparin safe in IBD?Severe bleeding on anticoagulation is rare

  23. Conclusions • All patients with IBD are probably at an increased risk of clots during disease flares • Absolute risk is low • The highest risk group appears to be inpatients with severe colitis • Inflammation • Immobility • Prophylaxis with LMWH is indicated in patients hospitalized for severe colitis or post-op • Enoxaparin, 40 mg SQ daily in adults

More Related